Reducing opioid use disorder and overdose deaths in the United States: A dynamic modeling analysis

Author:

Stringfellow Erin J.1ORCID,Lim Tse Yang2ORCID,Humphreys Keith3ORCID,DiGennaro Catherine1ORCID,Stafford Celia4ORCID,Beaulieu Elizabeth1ORCID,Homer Jack25ORCID,Wakeland Wayne6ORCID,Bearnot Benjamin7ORCID,McHugh R. Kathryn8,Kelly John9ORCID,Glos Lukas10ORCID,Eggers Sara L.10,Kazemi Reza10,Jalali Mohammad S.12ORCID

Affiliation:

1. Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

2. Sloan School of Management, Massachusetts Institute of Technology, Cambridge, MA, USA.

3. Veterans Affairs and Stanford University Medical Centers, Palo Alto, CA, USA.

4. Harvard Business School, Boston, MA, USA.

5. Homer Consulting, Barrytown, NY, USA.

6. Systems Science Program, Portland State University, Portland, OR, USA.

7. Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.

8. Division of Alcohol, Drugs, and Addiction, McLean Hospital, Harvard Medical School, Boston, MA, USA.

9. Center for Addiction Medicine, Massachusetts General Hospital, Boston, MA, USA.

10. Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.

Abstract

Opioid overdose deaths remain a major public health crisis. We used a system dynamics simulation model of the U.S. opioid-using population age 12 and older to explore the impacts of 11 strategies on the prevalence of opioid use disorder (OUD) and fatal opioid overdoses from 2022 to 2032. These strategies spanned opioid misuse and OUD prevention, buprenorphine capacity, recovery support, and overdose harm reduction. By 2032, three strategies saved the most lives: (i) reducing the risk of opioid overdose involving fentanyl use, which may be achieved through fentanyl-focused harm reduction services; (ii) increasing naloxone distribution to people who use opioids; and (iii) recovery support for people in remission, which reduced deaths by reducing OUD. Increasing buprenorphine providers’ capacity to treat more people decreased fatal overdose, but only in the short term. Our analysis provides insight into the kinds of multifaceted approaches needed to save lives.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference79 articles.

1. Centers for Disease Control and Prevention National Vital Statistics System Mortality Multiple Cause-of-Death (2022); www.cdc.gov/nchs/data_access/vitalstatsonline.htm#Mortality_Multiple.

2. National Center for Health Statistics Mortality Multiple Cause-of-Death Public Use Data Files and Documentation (2021); www.cdc.gov/nchs/data_access/vitalstatsonline.htm#Mortality_Multiple.

3. U.S. Drug Enforcement Administration "2020 National Drug Threat Assessment (NDTA)" (2021)

4. www.dea.gov/sites/default/files/2021-02/DIR-008-21 2020 National Drug Threat Assessment_WEB.pdf.

5. U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration HHS releases $1.5 billion to states tribes to combat opioid crisis; www.samhsa.gov/newsroom/press-announcements/202008270530.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3